期刊文献+

康柏西普联合577nm微脉冲激光治疗糖尿病性黄斑水肿临床观察 被引量:32

Clinical effect of Conbercept intravitreal injection combined with 577nm micro-pulse laser on the treatment of diabetic macular edema
下载PDF
导出
摘要 目的:探讨玻璃体腔内注射康柏西普联合577nm微脉冲激光治疗糖尿病性黄斑水肿(diabetic macular edema,DME)的临床疗效。方法:回顾性研究。选取2014-06/12在宝鸡市人民医院眼科经眼底检查、眼底荧光素血管造影(fluorescein fundus angiography,FFA)及光学相干断层扫描(optical coherence tomography,OCT)检查确诊的DME患者64例64眼,按所采用治疗方法不同分为试验组和对照组各32例。试验组给予玻璃体腔内注射康柏西普联合577nm微脉冲激光治疗;对照组给予577nm微脉冲激光治疗,对比分析两组患者治疗前后最佳矫正视力(best corrected visual acuity,BCVA)和黄斑中心厚度(central macular thickness,CMT)的变化。结果:对两组患者BCVA和CMT分别采用两因素重复测量方差分析结果表明,两组BCVA和CMT在组间的处理效应与时间效应的交互作用均有明显统计学意义(F=46.92,P<0.01;F=60.231,P<0.01),处理主效应也均有明显统计学意义(F=12.16,P<0.01;F=8.983,P<0.01),两种治疗方法的疗效有明显的差异,试验组的BCVA和CMT指标优于对照组。时间主效应有明显统计学意义(F=116.14,P<0.01;F=397.376,P<0.01),BCVA均数随治疗时间延长而增加,CMT均数随治疗时间延长而减少。结论:玻璃体腔内注射康柏西普联合577nm微脉冲激光在治疗DME上,减轻黄斑水肿、提高患者视力方面效果更优于单纯微脉冲光凝治疗。 AIM:To investigate the clinical effect of Conbercept intravitreal injection combined with 577 nm micro-pulse laser on the treatment of diabetic macular edema(DME).METHODS:From June to December in 2014,after the diagnosis was confirmed by fundus examination,fundus fluorescein angiography(FFA) and optical coherence tomography(OCT),64 patients(64 eyes) from department of ophthalmology in Baoji Peoples Hospital with DME were randomly divided into experiment group(32 cases) and control group(32 cases).The experiment group received 577 nm micro-pulse laser combined with intravitreal injection of Conbercept.The control group was treated with 577 nm micro-pulse laser.The best corrected visual acuity(BCVA) and central macular thickness(CMT) of two groups before and after treatments were compared.RESULTS:The ANOVA for two-way repeated measures was used to analyze the data of BCVA and CMT between two groups.The results showed that the interaction between treatment effects and time effects in BCVA and CMT was significant(F=46.92,P〈0.01;F=60.231,P〈0.01),the main effect of the treatment were significant(F=12.16,P〈0.01;F= 8.983,P〈0.01).There was significant difference on the effect between the two treatments,BCVA and CMT of experiment group were better than those of control group.The main time effect was statistically significant(F=116.14,P〈0.01;F=397.376,P〈0.01).The BCVA means increased with the treatment time,but the CMT means decreased.CONCLUSION:Intravitreal injection of Conbercept combined with 577 nm micropulse laser on the treatment of DME was much better on reducing macular edema and improving visual acuity than the micro- pulse treatment.
出处 《国际眼科杂志》 CAS 2015年第11期1942-1944,共3页 International Eye Science
基金 宝鸡市自然科学基金资助项目(No.11SF04-5,12SF4-7)~~
关键词 康柏西普 微脉冲激光 黄斑中心厚度 最佳矫正视力 Conbercept micro-pulse laser central macular thickness the best corrected visual acuity
  • 相关文献

参考文献10

  • 1Ciardella AP, Klancnik J, Schiff W, et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 2004;88(9) :1131-1136.
  • 2梁丽,单明华,徐斌,王杰,杨露.传统格栅样激光与577nm黄色微脉冲激光光凝治疗视网膜静脉阻塞并发黄斑水肿的疗效比较[J].河北医科大学学报,2015,36(3):356-358. 被引量:12
  • 3徐斌,戴奕娟,梁丽,杨露.传统格栅样激光与577nm黄色微脉冲激光光凝治疗黄斑水肿疗效对比[J].眼科新进展,2014,34(2):181-183. 被引量:12
  • 4Li X, Xu G, Wang Y, et al . Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study : AURORA study. Ophthalmology 2014 ; 121 (9) :1740-1747.
  • 5Chun MY, Hwang HS, Cho HY, et al . Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. J Clin Endocrinol Metab 2010 ;95 (7) : 3547-3551.
  • 6Funastu H, Yanashita H, Lkeda T, et al. Angiotensin- 11 and vascular endothelial. Am J Ophthalmol 2002 ; 133 ( 2 ) :537-543.
  • 7Bhisitkul RB. Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br J Ophthalmol 2006 ;90(12) :1542-1547.
  • 8Crawford TN, Alfaro DV 3rd, Kerrison JB, et al. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009 ;5( 1 ) :8-13.
  • 9Burak T, Tanyildizi R. The frequency of the nonresponsiveness to intravitreal injection of the anti-vascular endothelial growth factor agent in neovascular age related macular degeneration. Int J Ophthalmic Pathol 2013 ;2(3 ) :2324-2326.
  • 10谢婷玉,郭乔茜,王燕,王清,陈雪艺.阈下微脉冲激光与氩离子激光治疗糖尿病性黄斑水肿的临床随机对照研究(英文)[J].国际眼科杂志,2013,13(12):2370-2372. 被引量:7

二级参考文献35

  • 1张祺,冯劼,李培凤,金翼.Lucentis联合氪黄激光治疗视网膜分支静脉阻塞黄斑水肿的疗效观察[J].眼科新进展,2013,33(12):1148-1149. 被引量:2
  • 2黎晓新.热效应激光治疗的波长选择//黎晓新,廖菊生.眼底病激光治疗指南.北京:人民卫生出版社,2009:89.
  • 3Lain DS, Ritch R, Rao SK. Laser and Pharmacologic Therapies for Macular Diseases. Section B the sixth ed.
  • 4Li SZ. Ophthalmic surgery. Beijing: People's Health Publishing House, 2002:726, 951.
  • 5Finger PT, Packer S, Paglione RW. Thermoradiotherapy of choroidal melanoma. Ophthalmology 1989 ,96:1384-1388.
  • 6EarlyTreatment Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema. Int Ophthalmol Clinic 1987 ,27:265-272.
  • 7Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Arch Ophthalmol 1994 , 112:480-488.
  • 8Moorman CM, Hamihon AM. Clinical applications of the mieropulse diode laser. Eye 1999 ,13:145-150.
  • 9Laursen ML, Moeller F, Sander B, Sjoelie AK. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol 2004 , 88 : 1173-1179.
  • 10Akduman L, Olk ILl. Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic maeular edema (DDME). Ophthalmic Surg Lasers 1999 ,30:705.

共引文献20

同被引文献230

引证文献32

二级引证文献308

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部